The antiretroviral therapy (ART) coverage in Indonesia has experienced a steady increase, starting from 7 units of adult women living with HIV in 2013 to reaching 19 units in 2023. The year-on-year variation over the past decade has shown a decelerating growth rate, initially marked by high double-digit growth percentages until 2016 and slowing down significantly to single-digit percentages from 2017 onwards. As of 2023, the ART coverage stood at 19 units, reflecting a 5.56% increase over the previous year.
Looking at the compound annual growth rate (CAGR) over the last five years, there has been a notable decline, with the CAGR dropping from 21.06% in 2016 to 4.84% in 2023. Forecasted data suggests that the growth will continue but at an even slower pace, with a projected 5-year CAGR of 2.83%, leading to an expected coverage of 23 units by 2028. This forecast indicates a total growth rate of 15% over the next five years.
Future trends to watch for include the potential impacts of new health policies, international support, and advancements in HIV treatment technologies which may influence the anticipated slower growth rates in ART coverage. Additionally, monitoring the accessibility and affordability of ART for patients will be crucial in addressing the growing demand and ensuring sustained increases in coverage.
